Search Results - Burns, Shelbi

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease

    Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease by Hesse, Andrew N., Fabricius, William, Thomas, Christian A., Gaindh, Ramesh, Christman, Robert, Selvam, Pavalan, Prego, Matthew, Lewis, Gregory, Uvalic, Jasmina, Bergeron, Daniel, Burns, Shelbi, Sisson, Bridgette, Kelly, Kevin, Rueter, Jens, Reddi, Honey V.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 1034: Genotyping of patient-derived xenograft tumors using short tandem repeats: Challenges and observations in ensuring concordance across passages for effective preclinical studies

    Abstract 1034: Genotyping of patient-derived xenograft tumors using short tandem repeats: Challenges and observations in ensuring concordance across passages for effective preclini... by Sisson, Bridgette, Hesse, Andrew, Soucy, Melissa, Bergeron, Daniel, Burns, Shelbi, Kelly, Kevin, Jocoy, Emily, Bundy, Margaret, Reddi, Honey V.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 3428: Development and validation of the plasma monitor test system

    Abstract 3428: Development and validation of the plasma monitor test system by Kelly, Kevin J., Uvalic, Jasmina, Bergeron, Daniel, Burns, Shelbi, Soucy, Melissa, Ananda, Guruprasad, Hesse, Andrew, Selvam, Pavalan Panneer, Reddi, Honey V.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    37. Comparative analysis of methods for extracting cell-free tumor DNA (cfDNA) from cerebral spinal fluid (CSF) specimens

    37. Comparative analysis of methods for extracting cell-free tumor DNA (cfDNA) from cerebral spinal fluid (CSF) specimens by Bergeron, Daniel, Kelly, Kevin, Soucy, Melissa, Burns, Shelbi, Uvalic, Jasmina, Peracchio, Michael, Reddi, Honey V.

    Published in Cancer genetics
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    17. Molecular profiling of gynecologic cancers – clinical experience evaluating ∼80 cases for treatment and management of disease

    17. Molecular profiling of gynecologic cancers – clinical experience evaluating ∼80 cases for treatment and management of disease by Nie, Qian, Omerza, Gregory, Hesse, Andrew, Burns, Shelbi, Kelly, Kevin, Reddi, Honey

    Published in Cancer genetics
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Molecular profiling of CNS tumors for the treatment and management of disease

    Molecular profiling of CNS tumors for the treatment and management of disease by Nie, Qian, Hsiao, Meng-Chang, Chandok, Harshpreet, Rowe, Shannon, Prego, Matthew, Meyers, Bridgette, Omerza, Gregory, Hesse, Andrew, Uvalic, Jasmina, Soucy, Melissa, Bergeron, Daniel, Peracchio, Michael, Burns, Shelbi, Kelly, Kevin, Rueter, Jens, Reddi, Honey V.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Molecular profiling of gynecologic cancers for treatment and management of disease – demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants

    Molecular profiling of gynecologic cancers for treatment and management of disease – demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and re... by Nie, Qian, Omerza, Gregory, Chandok, Harshpreet, Prego, Matthew, Hsiao, Meng-Chang, Meyers, Bridgette, Hesse, Andrew, Uvalic, Jasmina, Soucy, Melissa, Bergeron, Daniel, Peracchio, Michael, Burns, Shelbi, Kelly, Kevin, Rowe, Shannon, Rueter, Jens, Reddi, Honey V

    Published in Cancer genetics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay

    Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay by Selvam, Pavalan, Hsiao, Meng-Chang, Omerza, Gregory, Bergeron, Daniel, Rowe, Shannon, Uvalic, Jasmina, Soucy, Melissa, Peracchio, Michael, Burns, Shelbi, Meyers, Bridgette, Prego, Matthew, Nie, Qian, Ananda, Guruprasad, Chandok, Harshpreet, Kelly, Kevin, Hesse, Andrew, Reddi, Honey V.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease

    Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease by Hesse, Andrew N, Fabricius, William, Thomas, Christian A, Gaindh, Ramesh, Christman, Robert, Selvam, Pavalan, Prego, Matthew, Lewis, Gregory, Uvalic, Jasmina, Bergeron, Daniel, Burns, Shelbi, Sisson, Bridgette, Kelly, Kevin, Rueter, Jens, Reddi, Honey V

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: